• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023

    1/18/23 10:00:59 AM ET
    $ADBE
    $AJG
    $ALNY
    $AMYT
    Computer Software: Prepackaged Software
    Technology
    Specialty Insurers
    Finance
    Get the next $ADBE alert in real time by email

    Upgrades

    According to Citigroup, the prior rating for Pegasystems Inc (NASDAQ:PEGA) was changed from Neutral to Buy. In the third quarter, Pegasystems showed an EPS of $0.34, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $102.50 and a 52-week-low of $29.05. Pegasystems closed at $35.62 at the end of the last trading period.

    Mizuho upgraded the previous rating for Oatly Group AB (NASDAQ:OTLY) from Neutral to Buy. Oatly Group earned $0.18 in the third quarter, compared to $0.07 in the year-ago quarter. The stock has a 52-week-high of $7.98 and a 52-week-low of $1.28. At the end of the last trading period, Oatly Group closed at $2.69.

    Barclays upgraded the previous rating for Magellan Midstream Partners LP (NYSE:MMP) from Equal-Weight to Overweight. For the third quarter, Magellan Midstream had an EPS of $1.29, compared to year-ago quarter EPS of $1.09. At the moment, the stock has a 52-week-high of $54.40 and a 52-week-low of $44.79. Magellan Midstream closed at $52.65 at the end of the last trading period.

    Raymond James upgraded the previous rating for Natera Inc (NASDAQ:NTRA) from Market Perform to Outperform. Natera earned $1.25 in the third quarter, compared to $1.63 in the year-ago quarter. The current stock performance of Natera shows a 52-week-high of $74.82 and a 52-week-low of $26.10. Moreover, at the end of the last trading period, the closing price was at $40.00.

    According to Raymond James, the prior rating for Myriad Genetics Inc (NASDAQ:MYGN) was changed from Market Perform to Outperform. In the third quarter, Myriad Genetics showed an EPS of $0.19, compared to $0.02 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.18 and a 52-week-low of $13.92. Myriad Genetics closed at $18.56 at the end of the last trading period.

    For Willis Towers Watson PLC (NASDAQ:WTW), Keefe, Bruyette & Woods upgraded the previous rating of Market Perform to Outperform. In the third quarter, Willis Towers Watson showed an EPS of $2.20, compared to $1.73 from the year-ago quarter. The stock has a 52-week-high of $258.43 and a 52-week-low of $187.89. At the end of the last trading period, Willis Towers Watson closed at $252.20.

    For Gap Inc (NYSE:GPS), Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. For the third quarter, Gap had an EPS of $0.71, compared to year-ago quarter EPS of $0.27. The current stock performance of Gap shows a 52-week-high of $18.46 and a 52-week-low of $7.79. Moreover, at the end of the last trading period, the closing price was at $12.83.

    Morgan Stanley upgraded the previous rating for Seagate Technology Holdings PLC (NASDAQ:STX) from Equal-Weight to Overweight. In the first quarter, Seagate Tech Hldgs showed an EPS of $0.48, compared to $2.35 from the year-ago quarter. The stock has a 52-week-high of $117.03 and a 52-week-low of $47.47. At the end of the last trading period, Seagate Tech Hldgs closed at $56.98.

    According to Evercore ISI Group, the prior rating for GoDaddy Inc (NYSE:GDDY) was changed from In-Line to Outperform. GoDaddy earned $0.63 in the third quarter, compared to $0.58 in the year-ago quarter. The current stock performance of GoDaddy shows a 52-week-high of $88.32 and a 52-week-low of $64.65. Moreover, at the end of the last trading period, the closing price was at $75.83.

    According to Citigroup, the prior rating for Check Point Software Technologies Ltd (NASDAQ:CHKP) was changed from Sell to Neutral. Check Point Software earned $1.77 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Check Point Software shows a 52-week-high of $149.62 and a 52-week-low of $107.54. Moreover, at the end of the last trading period, the closing price was at $130.03.

    See all analyst ratings upgrades.

    Downgrades

    For Snap Inc (NYSE:SNAP), OTR Global downgraded the previous rating of Positive to Mixed. For the third quarter, Snap had an EPS of $0.08, compared to year-ago quarter EPS of $0.17. The current stock performance of Snap shows a 52-week-high of $41.97 and a 52-week-low of $7.33. Moreover, at the end of the last trading period, the closing price was at $9.67.

    Redburn Partners downgraded the previous rating for Exxon Mobil Corp (NYSE:XOM) from Neutral to Sell. In the third quarter, Exxon Mobil showed an EPS of $4.45, compared to $1.58 from the year-ago quarter. At the moment, the stock has a 52-week-high of $114.66 and a 52-week-low of $69.81. Exxon Mobil closed at $112.93 at the end of the last trading period.

    SMBC Nikko downgraded the previous rating for PayPal Holdings Inc (NASDAQ:PYPL) from Neutral to Underperform. PayPal Holdings earned $1.08 in the third quarter, compared to $1.11 in the year-ago quarter. The current stock performance of PayPal Holdings shows a 52-week-high of $182.00 and a 52-week-low of $66.39. Moreover, at the end of the last trading period, the closing price was at $80.18.

    For Arthur J. Gallagher & Co (NYSE:AJG), Keefe, Bruyette & Woods downgraded the previous rating of Outperform to Market Perform. In the third quarter, Arthur J. Gallagher showed an EPS of $1.72, compared to $1.33 from the year-ago quarter. The current stock performance of Arthur J. Gallagher shows a 52-week-high of $201.51 and a 52-week-low of $147.32. Moreover, at the end of the last trading period, the closing price was at $195.65.

    DA Davidson downgraded the previous rating for Paya Holdings Inc (NASDAQ:PAYA) from Buy to Neutral. In the third quarter, Paya Holdings showed an EPS of $0.09, compared to $0.04 from the year-ago quarter. The stock has a 52-week-high of $9.72 and a 52-week-low of $4.51. At the end of the last trading period, Paya Holdings closed at $9.70.

    For Stronghold Digital Mining Inc (NASDAQ:SDIG), Compass Point downgraded the previous rating of Buy to Neutral. Stronghold Digital Mining earned $0.07 in the third quarter, compared to $0.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $14.43 and a 52-week-low of $0.40. Stronghold Digital Mining closed at $0.70 at the end of the last trading period.

    Stephens & Co. downgraded the previous rating for Signature Bank (NASDAQ:SBNY) from Overweight to Equal-Weight. Signature Bank earned $4.65 in the fourth quarter, compared to $4.34 in the year-ago quarter. The stock has a 52-week-high of $374.76 and a 52-week-low of $106.81. At the end of the last trading period, Signature Bank closed at $121.18.

    B of A Securities downgraded the previous rating for Levi Strauss & Co (NYSE:LEVI) from Buy to Neutral. For the third quarter, Levi Strauss had an EPS of $0.40, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $24.22 and a 52-week-low of $13.57. Levi Strauss closed at $16.28 at the end of the last trading period.

    According to B of A Securities, the prior rating for Graphite Bio Inc (NASDAQ:GRPH) was changed from Buy to Neutral. For the third quarter, Graphite Bio had an EPS of $0.45, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $11.30 and a 52-week-low of $1.59. At the end of the last trading period, Graphite Bio closed at $2.05.

    Citigroup downgraded the previous rating for BlackLine Inc (NASDAQ:BL) from Neutral to Sell. For the third quarter, BlackLine had an EPS of $0.21, compared to year-ago quarter EPS of $0.24. At the moment, the stock has a 52-week-high of $93.11 and a 52-week-low of $48.73. BlackLine closed at $70.16 at the end of the last trading period.

    According to HC Wainwright & Co., the prior rating for Neovasc Inc (NASDAQ:NVCN) was changed from Buy to Neutral. In the third quarter, Neovasc showed an EPS of $3.00, compared to $2.75 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.28 and a 52-week-low of $0.29. Neovasc closed at $27.80 at the end of the last trading period.

    According to HC Wainwright & Co., the prior rating for Amryt Pharma PLC (NASDAQ:AMYT) was changed from Buy to Neutral. In the third quarter, Amryt Pharma showed an EPS of $0.06, compared to $0.07 from the year-ago quarter. The stock has a 52-week-high of $14.77 and a 52-week-low of $5.61. At the end of the last trading period, Amryt Pharma closed at $14.70.

    According to Cowen & Co., the prior rating for YETI Holdings Inc (NYSE:YETI) was changed from Outperform to Market Perform. For the third quarter, YETI Holdings had an EPS of $0.63, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $71.89 and a 52-week-low of $27.86. At the end of the last trading period, YETI Holdings closed at $45.21.

    For Chegg Inc (NYSE:CHGG), Needham downgraded the previous rating of Buy to Hold. In the third quarter, Chegg showed an EPS of $0.21, compared to $0.20 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.64 and a 52-week-low of $15.66. Chegg closed at $24.44 at the end of the last trading period.

    Barclays downgraded the previous rating for Williams Companies Inc (NYSE:WMB) from Overweight to Equal-Weight. In the third quarter, Williams Companies showed an EPS of $0.48, compared to $0.34 from the year-ago quarter. At the moment, the stock has a 52-week-high of $37.97 and a 52-week-low of $27.32. Williams Companies closed at $32.78 at the end of the last trading period.

    Barclays downgraded the previous rating for UGI Corp (NYSE:UGI) from Equal-Weight to Underweight. In the fourth quarter, UGI showed an EPS of $0.00, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $47.04 and a 52-week-low of $31.19. At the end of the last trading period, UGI closed at $40.49.

    According to Raymond James, the prior rating for Mercantile Bank Corp (NASDAQ:MBWM) was changed from Outperform to Market Perform. In the fourth quarter, Mercantile Bank showed an EPS of $1.37, compared to $0.74 from the year-ago quarter. At the moment, the stock has a 52-week-high of $40.01 and a 52-week-low of $29.26. Mercantile Bank closed at $36.59 at the end of the last trading period.

    For Exact Sciences Corp (NASDAQ:EXAS), Raymond James downgraded the previous rating of Outperform to Market Perform. For the third quarter, Exact Sciences had an EPS of $0.84, compared to year-ago quarter EPS of $0.79. The stock has a 52-week-high of $84.46 and a 52-week-low of $29.27. At the end of the last trading period, Exact Sciences closed at $68.38.

    According to Raymond James, the prior rating for Veracyte Inc (NASDAQ:VCYT) was changed from Outperform to Market Perform. Veracyte earned $0.12 in the third quarter, compared to $0.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $33.23 and a 52-week-low of $14.85. Veracyte closed at $26.69 at the end of the last trading period.

    For Monarch Casino & Resort Inc (NASDAQ:MCRI), Macquarie downgraded the previous rating of Outperform to Neutral. In the third quarter, Monarch Casino & Resort showed an EPS of $1.41, compared to $1.15 from the year-ago quarter. At the moment, the stock has a 52-week-high of $94.26 and a 52-week-low of $54.01. Monarch Casino & Resort closed at $79.22 at the end of the last trading period.

    Morgan Stanley downgraded the previous rating for Skechers USA Inc (NYSE:SKX) from Overweight to Equal-Weight. For the third quarter, Skechers USA had an EPS of $0.55, compared to year-ago quarter EPS of $0.66. The stock has a 52-week-high of $49.89 and a 52-week-low of $31.28. At the end of the last trading period, Skechers USA closed at $46.22.

    According to Morgan Stanley, the prior rating for International Business Machines Corp (NYSE:IBM) was changed from Overweight to Equal-Weight. For the third quarter, IBM had an EPS of $1.81, compared to year-ago quarter EPS of $2.52. At the moment, the stock has a 52-week-high of $153.21 and a 52-week-low of $115.55. IBM closed at $145.19 at the end of the last trading period.

    For Morgan Stanley (NYSE:MS), Citigroup downgraded the previous rating of Buy to Neutral. For the fourth quarter, Morgan Stanley had an EPS of $1.31, compared to year-ago quarter EPS of $2.08. At the moment, the stock has a 52-week-high of $109.73 and a 52-week-low of $72.05. Morgan Stanley closed at $97.08 at the end of the last trading period.

    For Extra Space Storage Inc (NYSE:EXR), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the third quarter, Extra Space Storage had an EPS of $2.21, compared to year-ago quarter EPS of $1.85. The current stock performance of Extra Space Storage shows a 52-week-high of $222.35 and a 52-week-low of $139.97. Moreover, at the end of the last trading period, the closing price was at $153.10.

    According to JMP Securities, the prior rating for PennyMac Financial Services Inc (NYSE:PFSI) was changed from Market Outperform to Market Perform. For the third quarter, PennyMac Financial Servs had an EPS of $2.46, compared to year-ago quarter EPS of $3.80. The current stock performance of PennyMac Financial Servs shows a 52-week-high of $69.69 and a 52-week-low of $38.53. Moreover, at the end of the last trading period, the closing price was at $64.19.

    See all analyst ratings downgrades.

    Initiations

    With an Overweight rating, Cantor Fitzgerald initiated coverage on Prenetics Global Ltd (NASDAQ:PRE). The price target seems to have been set at $7.00 for Prenetics Global. In the third quarter, Prenetics Global showed an EPS of $0.30, compared to $2.65 from the year-ago quarter. The stock has a 52-week-high of $8.75 and a 52-week-low of $1.24. At the end of the last trading period, Prenetics Global closed at $1.53.

    With a Buy rating, BWS Financial initiated coverage on Seadrill Ltd (NYSE:SDRL). The price target seems to have been set at $50.00 for Seadrill. Seadrill earned $0.36 in the third quarter, compared to $0.55 in the year-ago quarter. At the moment, the stock has a 52-week-high of $36.01 and a 52-week-low of $24.51. Seadrill closed at $35.18 at the end of the last trading period.

    With a Hold rating, Canaccord Genuity initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX). The price target seems to have been set at $311.00 for Vertex Pharmaceuticals. Vertex Pharmaceuticals earned $4.01 in the third quarter, compared to $3.56 in the year-ago quarter. The current stock performance of Vertex Pharmaceuticals shows a 52-week-high of $324.75 and a 52-week-low of $221.69. Moreover, at the end of the last trading period, the closing price was at $311.98.

    With a Buy rating, Canaccord Genuity initiated coverage on Sigilon Therapeutics Inc (NASDAQ:SGTX). The price target seems to have been set at $6.00 for Sigilon Therapeutics. In the third quarter, Sigilon Therapeutics showed an EPS of $0.27, compared to $0.63 from the year-ago quarter. The current stock performance of Sigilon Therapeutics shows a 52-week-high of $2.23 and a 52-week-low of $0.29. Moreover, at the end of the last trading period, the closing price was at $0.41.

    Canaccord Genuity initiated coverage on Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) with a Buy rating. The price target for Alnylam Pharmaceuticals is set to $310.00. For the third quarter, Alnylam Pharmaceuticals had an EPS of $1.58, compared to year-ago quarter EPS of $1.59. The stock has a 52-week-high of $242.97 and a 52-week-low of $117.58. At the end of the last trading period, Alnylam Pharmaceuticals closed at $233.73.

    With a Buy rating, Roth Capital initiated coverage on Membership Collective Group Inc (NYSE:MCG). The price target seems to have been set at $7.00 for Membership Collective. For the third quarter, Membership Collective had an EPS of $0.19, compared to year-ago quarter EPS of $0.72. The current stock performance of Membership Collective shows a 52-week-high of $10.98 and a 52-week-low of $3.08. Moreover, at the end of the last trading period, the closing price was at $5.10.

    With a Buy rating, Roth Capital initiated coverage on Boyd Gaming Corp (NYSE:BYD). The price target seems to have been set at $70.00 for Boyd Gaming. For the third quarter, Boyd Gaming had an EPS of $1.48, compared to year-ago quarter EPS of $1.30. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $46.10. Boyd Gaming closed at $59.43 at the end of the last trading period.

    Barclays initiated coverage on KeyCorp (NYSE:KEY) with a Equal-Weight rating. The price target for KeyCorp is set to $34.00. In the third quarter, KeyCorp showed an EPS of $0.55, compared to $0.65 from the year-ago quarter. The stock has a 52-week-high of $27.17 and a 52-week-low of $15.26. At the end of the last trading period, KeyCorp closed at $18.02.

    With a Equal-Weight rating, Barclays initiated coverage on Enerplus Corp (NYSE:ERF). The price target seems to have been set at $28.00 for Enerplus. Enerplus earned $0.87 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $19.23 and a 52-week-low of $10.21. At the end of the last trading period, Enerplus closed at $17.58.

    With a Equal-Weight rating, Morgan Stanley initiated coverage on Kornit Digital Ltd (NASDAQ:KRNT). The price target seems to have been set at $27.00 for Kornit Digital. For the third quarter, Kornit Digital had an EPS of $0.21, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $111.78 and a 52-week-low of $19.44. At the end of the last trading period, Kornit Digital closed at $26.82.

    With an Outperform rating, BMO Capital initiated coverage on CrowdStrike Holdings Inc (NASDAQ:CRWD). The price target seems to have been set at $120.00 for CrowdStrike Holdings. In the third quarter, CrowdStrike Holdings showed an EPS of $0.40, compared to $0.17 from the year-ago quarter. At the moment, the stock has a 52-week-high of $242.00 and a 52-week-low of $92.25. CrowdStrike Holdings closed at $104.43 at the end of the last trading period.

    DA Davidson initiated coverage on Shopify Inc (NYSE:SHOP) with a Neutral rating. The price target for Shopify is set to $34.00. Shopify earned $0.02 in the third quarter, compared to $0.08 in the year-ago quarter. The stock has a 52-week-high of $1122.49 and a 52-week-low of $23.63. At the end of the last trading period, Shopify closed at $39.98.

    Scotiabank initiated coverage on SentinelOne Inc (NYSE:S) with a Sector Perform rating. The price target for SentinelOne is set to $13.00. For the third quarter, SentinelOne had an EPS of $0.16, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $48.46 and a 52-week-low of $12.69. SentinelOne closed at $14.51 at the end of the last trading period.

    With a Buy rating, Ascendiant Capital initiated coverage on Duos Technologies Group Inc (NASDAQ:DUOT). The price target seems to have been set at $5.00 for Duos Technologies Group. For the third quarter, Duos Technologies Group had an EPS of $0.30, compared to year-ago quarter EPS of $0.68.

    Mizuho initiated coverage on Palantir Technologies Inc (NYSE:PLTR) with a Neutral rating. The price target for Palantir Technologies is set to $7.00. Palantir Technologies earned $0.01 in the third quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $16.25 and a 52-week-low of $5.92. At the end of the last trading period, Palantir Technologies closed at $7.07.

    With a Buy rating, Deutsche Bank initiated coverage on Mobileye Global Inc (NASDAQ:MBLY). The price target seems to have been set at $48.00 for Mobileye Global. At the moment, the stock has a 52-week-high of $37.31 and a 52-week-low of $24.85. Mobileye Global closed at $31.55 at the end of the last trading period.

    DA Davidson initiated coverage on Salesforce Inc (NYSE:CRM) with a Neutral rating. The price target for Salesforce is set to $150.00. Salesforce earned $1.40 in the third quarter, compared to $1.27 in the year-ago quarter. The current stock performance of Salesforce shows a 52-week-high of $234.49 and a 52-week-low of $126.34. Moreover, at the end of the last trading period, the closing price was at $148.47.

    DA Davidson initiated coverage on Adobe Inc (NASDAQ:ADBE) with a Neutral rating. The price target for Adobe is set to $350.00. For the fourth quarter, Adobe had an EPS of $3.60, compared to year-ago quarter EPS of $3.20. The current stock performance of Adobe shows a 52-week-high of $540.46 and a 52-week-low of $274.73. Moreover, at the end of the last trading period, the closing price was at $344.38.

    DA Davidson initiated coverage on Oracle Corp (NYSE:ORCL) with a Neutral rating. The price target for Oracle is set to $85.00. For the second quarter, Oracle had an EPS of $1.21, compared to year-ago quarter EPS of $1.21. The current stock performance of Oracle shows a 52-week-high of $89.47 and a 52-week-low of $60.78. Moreover, at the end of the last trading period, the closing price was at $88.60.

    With a Sector Outperform rating, Scotiabank initiated coverage on Check Point Software Technologies Ltd (NASDAQ:CHKP). The price target seems to have been set at $160.00 for Check Point Software. Check Point Software earned $1.77 in the third quarter, compared to $1.65 in the year-ago quarter. The current stock performance of Check Point Software shows a 52-week-high of $149.62 and a 52-week-low of $107.54. Moreover, at the end of the last trading period, the closing price was at $130.03.

    Scotiabank initiated coverage on Zscaler Inc (NASDAQ:ZS) with a Sector Outperform rating. The price target for Zscaler is set to $115.00. Zscaler earned $0.29 in the first quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $290.47 and a 52-week-low of $99.64. Zscaler closed at $113.51 at the end of the last trading period.

    Scotiabank initiated coverage on Fortinet Inc (NASDAQ:FTNT) with a Sector Outperform rating. The price target for Fortinet is set to $65.00. Fortinet earned $0.33 in the third quarter, compared to $0.20 in the year-ago quarter. The stock has a 52-week-high of $357.58 and a 52-week-low of $42.61. At the end of the last trading period, Fortinet closed at $50.10.

    Wolfe Research initiated coverage on National Storage Affiliates Trust (NYSE:NSA) with a Peer Perform rating. National Storage earned $0.72 in the third quarter, compared to $0.57 in the year-ago quarter. The current stock performance of National Storage shows a 52-week-high of $67.44 and a 52-week-low of $34.90. Moreover, at the end of the last trading period, the closing price was at $38.57.

    With an Outperform rating, Wolfe Research initiated coverage on CubeSmart (NYSE:CUBE). The price target seems to have been set at $48.00 for CubeSmart. CubeSmart earned $0.66 in the third quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $54.95 and a 52-week-low of $36.82. CubeSmart closed at $42.39 at the end of the last trading period.

    With a Sector Perform rating, Scotiabank initiated coverage on Informatica Inc (NYSE:INFA). The price target seems to have been set at $15.00 for Informatica. Informatica earned $0.18 in the third quarter, compared to $0.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.50 and a 52-week-low of $14.96. Informatica closed at $16.67 at the end of the last trading period.

    Rosenblatt initiated coverage on Coherent Corp (NASDAQ:COHR) with a Buy rating. The price target for Coherent is set to $55.00. In the first quarter, Coherent showed an EPS of $1.04, compared to $2.32 from the year-ago quarter.

    With an Outperform rating, Wedbush initiated coverage on Nuvalent Inc (NASDAQ:NUVL). The price target seems to have been set at $39.00 for Nuvalent. For the third quarter, Nuvalent had an EPS of $0.41, compared to year-ago quarter EPS of $0.39. The current stock performance of Nuvalent shows a 52-week-high of $40.43 and a 52-week-low of $7.09. Moreover, at the end of the last trading period, the closing price was at $33.30.

    See all analyst ratings initiations.

    Get the next $ADBE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADBE
    $AJG
    $ALNY
    $AMYT

    CompanyDatePrice TargetRatingAnalyst
    Zscaler Inc.
    $ZS
    2/13/2026$228.00Mkt Perform → Outperform
    Bernstein
    Williams Companies Inc.
    $WMB
    2/13/2026$84.00Sector Perform → Sector Outperform
    Scotiabank
    CrowdStrike Holdings Inc.
    $CRWD
    2/13/2026$446.00Hold → Buy
    HSBC Securities
    Check Point Software Technologies Ltd.
    $CHKP
    2/13/2026$240.00 → $210.00Outperform
    BMO Capital Markets
    Vertex Pharmaceuticals Incorporated
    $VRTX
    2/13/2026$540.00Perform → Outperform
    Oppenheimer
    Shopify Inc.
    $SHOP
    2/12/2026$150.00Neutral → Outperform
    Mizuho
    Shopify Inc.
    $SHOP
    2/12/2026$159.00Hold → Buy
    TD Cowen
    Pegasystems Inc.
    $PEGA
    2/12/2026$48.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kinsella Patrick bought $200,588 worth of shares (2,250 units at $89.15) and was granted 1,963 shares, increasing direct ownership by 14% to 34,210 units (SEC Form 4)

    4 - PennyMac Financial Services, Inc. (0001745916) (Issuer)

    2/13/26 6:22:45 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    Director Hammond Michael P. bought $67,205 worth of Ordinary Shares (241 units at $278.86), increasing direct ownership by 11% to 2,505 units (SEC Form 4)

    4 - WILLIS TOWERS WATSON PLC (0001140536) (Issuer)

    2/13/26 4:01:10 PM ET
    $WTW
    Specialty Insurers
    Finance

    Director Farr David N bought $304,000 worth of shares (1,000 units at $304.00), increasing direct ownership by 12% to 9,258 units (SEC Form 4)

    4 - INTERNATIONAL BUSINESS MACHINES CORP (0000051143) (Issuer)

    1/30/26 5:35:34 PM ET
    $IBM
    Computer Manufacturing
    Technology

    $ADBE
    $AJG
    $ALNY
    $AMYT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 30, 2025 - FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain

    For Immediate Release: January 30, 2025 Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx reduces pain by targeting a pain-signaling pathway involving sodium channels in the peripheral nervous system, before pain signals reach the brain.  Journavx is the first dr

    1/30/25 5:46:14 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for GIVLAARI issued to ALNYLAM PHARMS INC

    Submission status for ALNYLAM PHARMS INC's drug GIVLAARI (SUPPL-7) with active ingredient GIVOSIRAN SODIUM has changed to 'Approval' on 04/29/2024. Application Category: NDA, Application Number: 212194, Application Classification: Labeling

    4/30/24 1:44:03 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Extra Space Storage Inc. Announces 1st Quarter 2026 Dividend

    SALT LAKE CITY, Feb. 13, 2026 /PRNewswire/ -- Extra Space Storage Inc. (the "Company") (NYSE:EXR) announced today that the Company's board of directors has declared a first quarter 2026 dividend of $1.62 per share on the common stock of the Company.  The dividend is payable on March 31, 2026, to stockholders of record at the close of business on March 16, 2026.  About Extra Space Storage Inc. Extra Space Storage Inc., headquartered in Salt Lake City, is a fully integrated, self-administered and self-managed real estate investment trust, and a member of the S&P 500.  As of Sept

    2/13/26 5:17:00 PM ET
    $EXR
    Real Estate Investment Trusts
    Real Estate

    Morgan Stanley Declares Dividends on Its Preferred Stock

    Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $289.61 per share (equivalent to $0.289613 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $445.31 per share (equivalent to $0.445313 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $429.69 per share (equivalent to $0.429688 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I - $398.44 per sh

    2/13/26 4:30:00 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

    Fourth quarter and 2025 highlights Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Precision Oncology revenue of $183 million Total 2025 revenue of $3.25 billion, an increase of 18% on a reported and core revenue basis, with Screening revenue of $2.53 billion and Precision Oncology revenue of $717 million Operating cash flow was $491 million and free cash flow was $357 million for the full-year 2025, an improvement of 133% and 379%, respectively Net loss was $208 million and adjusted EBITDA was $400 million for the full-year 2025, an improvement of $821 million and $77 million, resp

    2/13/26 4:05:00 PM ET
    $EXAS
    Medical Specialities
    Health Care

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Zscaler upgraded by Bernstein with a new price target

    Bernstein upgraded Zscaler from Mkt Perform to Outperform and set a new price target of $228.00

    2/13/26 8:27:21 AM ET
    $ZS
    EDP Services
    Technology

    Williams Cos upgraded by Scotiabank with a new price target

    Scotiabank upgraded Williams Cos from Sector Perform to Sector Outperform and set a new price target of $84.00

    2/13/26 8:27:11 AM ET
    $WMB
    Natural Gas Distribution
    Utilities

    CrowdStrike upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded CrowdStrike from Hold to Buy and set a new price target of $446.00

    2/13/26 8:22:01 AM ET
    $CRWD
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jacobson Jonathon S was granted 1,963 shares, increasing direct ownership by 23% to 10,579 units (SEC Form 4)

    4 - PennyMac Financial Services, Inc. (0001745916) (Issuer)

    2/13/26 8:16:49 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    Director Perlowitz Jeffrey A. was granted 2,295 shares, increasing direct ownership by 13% to 20,302 units (SEC Form 4)

    4 - PennyMac Financial Services, Inc. (0001745916) (Issuer)

    2/13/26 6:47:39 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    Director Tozer Theodore W was granted 1,963 shares, increasing direct ownership by 8% to 26,998 units (SEC Form 4)

    4 - PennyMac Financial Services, Inc. (0001745916) (Issuer)

    2/13/26 6:32:27 PM ET
    $PFSI
    Finance: Consumer Services
    Finance

    $ADBE
    $AJG
    $ALNY
    $AMYT
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Exact Sciences Corporation

    SCHEDULE 13G/A - EXACT SCIENCES CORP (0001124140) (Subject)

    2/13/26 5:32:39 PM ET
    $EXAS
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Vertex Pharmaceuticals Incorporated

    10-K - VERTEX PHARMACEUTICALS INC / MA (0000875320) (Filer)

    2/13/26 4:20:09 PM ET
    $VRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form FWP filed by Morgan Stanley

    FWP - MORGAN STANLEY (0000895421) (Subject)

    2/13/26 4:12:14 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Leadership Updates

    Live Leadership Updates

    View All

    Formula 1 Phenom Ollie Bearman Joins Prenetics' IM8 Health as Global Ambassador and Shareholder

    Ollie Bearman becomes the latest elite athlete to invest in NASDAQ:PRE, underscoring a deep belief in the brand's mission and products.IM8, co-founded by David Beckham, continues to attract top-tier athletes who prioritize scientifically validated and trusted nutritional support.IM8 has become one of the fastest-growing supplement brands globally, achieving an extraordinary US$100 million in Annual Recurring Revenue in just 11 months from launch.Bearman's rapid rise – including a historic points-scoring Ferrari debut at just 18—cements his reputation as one of motorsport's brightest young talents. NEW YORK, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ:PRE), a leading

    2/13/26 8:00:00 AM ET
    $PRE
    Blank Checks
    Finance

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Chegg Appoints Karine Allouche as General Manager, Language Learning, Worldwide and Skills Integration, Europe

    Chegg, Inc. (NYSE:CHGG), a global learning company, today announced that Karine Allouche will join Busuu, Chegg's language learning business, as General Manager of Language Learning, Worldwide, and Skills Integration, Europe, effective February 9, 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209423954/en/Karine Allouche In her role, Karine will focus on strengthening execution, accelerating growth, and deepening collaboration across the company, in partnership with Chegg's leadership team and the board. In addition to leading language learning, Karine will own Chegg's European commercial engine and play a key role in

    2/9/26 9:05:00 AM ET
    $CHGG
    Other Consumer Services
    Real Estate

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by KeyCorp

    SC 13D/A - KEYCORP /NEW/ (0000091576) ()

    1/5/94 12:00:00 AM ET
    $KEY
    Major Banks
    Finance

    Amendment: SEC Form SC 13D/A filed by SentinelOne Inc.

    SC 13D/A - SentinelOne, Inc. (0001583708) (Subject)

    12/12/24 6:30:27 PM ET
    $S
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Palantir Technologies Inc.

    SC 13G/A - Palantir Technologies Inc. (0001321655) (Subject)

    11/14/24 5:47:09 PM ET
    $PLTR
    Computer Software: Prepackaged Software
    Technology

    $ADBE
    $AJG
    $ALNY
    $AMYT
    Financials

    Live finance-specific insights

    View All

    Extra Space Storage Inc. Announces 1st Quarter 2026 Dividend

    SALT LAKE CITY, Feb. 13, 2026 /PRNewswire/ -- Extra Space Storage Inc. (the "Company") (NYSE:EXR) announced today that the Company's board of directors has declared a first quarter 2026 dividend of $1.62 per share on the common stock of the Company.  The dividend is payable on March 31, 2026, to stockholders of record at the close of business on March 16, 2026.  About Extra Space Storage Inc. Extra Space Storage Inc., headquartered in Salt Lake City, is a fully integrated, self-administered and self-managed real estate investment trust, and a member of the S&P 500.  As of Sept

    2/13/26 5:17:00 PM ET
    $EXR
    Real Estate Investment Trusts
    Real Estate

    Morgan Stanley Declares Dividends on Its Preferred Stock

    Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $289.61 per share (equivalent to $0.289613 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $445.31 per share (equivalent to $0.445313 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $429.69 per share (equivalent to $0.429688 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I - $398.44 per sh

    2/13/26 4:30:00 PM ET
    $MS
    Investment Bankers/Brokers/Service
    Finance

    Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results

    Fourth quarter and 2025 highlights Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Precision Oncology revenue of $183 million Total 2025 revenue of $3.25 billion, an increase of 18% on a reported and core revenue basis, with Screening revenue of $2.53 billion and Precision Oncology revenue of $717 million Operating cash flow was $491 million and free cash flow was $357 million for the full-year 2025, an improvement of 133% and 379%, respectively Net loss was $208 million and adjusted EBITDA was $400 million for the full-year 2025, an improvement of $821 million and $77 million, resp

    2/13/26 4:05:00 PM ET
    $EXAS
    Medical Specialities
    Health Care